it's a hedge and an incentive all at once. They ha
Post# of 30027
(Total Views: 555)
Posted On: 07/06/2019 3:05:42 PM
.jpg)
it's a hedge and an incentive all at once. They have the rights to more shares if they start to see success. they have to pay for that right with the 20% premium. But Todos is allowing that dilution/participation to in part pay for the IPO, give them access to more capital later, even if it's then at a significant discount to how they could raise.
key thing here is even after all the bs Amarantus is going to have 78 million pre-rs shares, 49.99%, that's the biggest piece of news, the sequence of the mechanisms. At market today, thats $20M, a market valued asset in excess of our converting debt. Shit we might even have book value lol. We're also the largest shareholder, no other group has anywhere near as much control. Todos is effectively our for awhile unless everyone else is on the same team, which may be the case come another raise in the future.
Hopefully this nasdaq transition goes off without a hitch.
key thing here is even after all the bs Amarantus is going to have 78 million pre-rs shares, 49.99%, that's the biggest piece of news, the sequence of the mechanisms. At market today, thats $20M, a market valued asset in excess of our converting debt. Shit we might even have book value lol. We're also the largest shareholder, no other group has anywhere near as much control. Todos is effectively our for awhile unless everyone else is on the same team, which may be the case come another raise in the future.
Hopefully this nasdaq transition goes off without a hitch.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼